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Dear editor,
Anticoagulant-induced skin necrosis is a rare and 
serious complication of treatment with these com-
monly prescribed drugs. Few cases of heparin in-
duced skin necrosis have been reported in literature 
and only a small number of them was attributed to 
enoxaparin (1). We report a case with a delayed diag-
nosis and fatal outcome.
A 78-year-old obese woman with history of hyper-
tension, poorly controlled diabetes mellitus, and car-
diomyopathy was admitted to the Geriatric Hospital. 
Six days earlier she had fallen and sustained an intra-
capsular hip fracture which had been treated conser-
vatively. For the prevention of deep vein thrombosis, 
low molecular weight heparin (Enoxaparin Sodium 
30 mg, s.c. every 12 hours) was started on the day of 
injury. Her other routine medications included insulin 
glargine, metformin, enalapril, omeprazole, amlodip-
ine, citalopram, atorvastatin, and pain medication. 
At admission she was afebrile, with stable vital signs. 
Clinical examination revealed redness at the sites of 
subcutaneous injection of enoxaparin, as well small 
purpuric lesions on the trunk and extremities. Over 
the following few days, new progressive, painful, and 
slightly indurated erythematous lesions were noted 
on the breasts, face, abdomen, and legs. Some of the 
purpuric lesions became bullous, with subsequent 
central necrosis (Figure 1). The diagnosis of enoxapa-
rin-induced skin necrosis was proposed and the treat-
ment was discontinued. Heparin-induced thrombo-
cytopenia, disseminated intravascular coagulation, 
and sepsis were excluded in this case based on the 
clinical and laboratory findings. Chest radiography 
and clinical features of the lesions excluded fat em-
bolism. Despite intensive supportive care our patient 
died from multiple organ dysfunction 16 days after 
the initiation of enoxaparin.  
Thromboprophylaxis has become established 
in clinical practice as a safe and effective means of 
decreasing venous thromboembolic events in sur-
gical patients. Enoxaparin, a low-molecular-weight 
heparin, is the standard agents used for antithrom-
botic therapy and prophylaxis. Despite widespread 
use, reports about adverse effects from enoxaparin 
are very scarce (2). Heparin-induced skin necrosis 
typically affects middle-aged women with a history 
of thrombotic disease. The skin necrosis occurs be-
tween day 5 and 11 following initiation of therapy (3-
5). The first symptoms are usually described as painful 
erythematous, subcutaneous lesions with edema, at 
the injection sites. Subsequently, bullous transforma-
tion is observed before full-skin necrosis occurs (5,6). 
Our experience with this case highlights the impor-
tance of early recognition of this adverse event and 
careful supervision of all patients who receive this 
medication. 
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Figure 1. Cutaneous lesions 15 days after initiation of 
enoxaparin. 
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